financetom
Market
financetom
/
Market
/
US Futures Rise Pre-Bell as Investors Await Key Employment, Manufacturing Data
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
US Futures Rise Pre-Bell as Investors Await Key Employment, Manufacturing Data
Nov 1, 2024 6:04 AM

08:11 AM EDT, 11/01/2024 (MT Newswires) -- US stock futures are moving higher in Friday's premarket activity as investors await key employment and manufacturing data set to be released later in the morning.

The Dow Jones Industrial Average futures were up 0.4%, S&P 500 futures gained 0.4%, and Nasdaq futures were rising 0.5%.

Oil prices were surging higher, with front-month global benchmarks Brent crude and West Texas Intermediate crude rising 2% and 2.2% respectively.

The unemployment rate for October is expected to remain unchanged at 4.1%, while nonfarm payrolls for the month are forecast to fall to 106,000 from 254,000 the previous month, according to Bloomberg.

Meanwhile, the Manufacturing Purchasing Managers' Index is expected to stay unchanged for October at 47.8 and remain below the 50-point threshold demarcating contraction from expansion, according to Bloomberg.

In equities, shares of Globalstar ( GSAT ) jumped 52% after the company said in a regulatory filing Friday that it has updated its service agreements with Apple (AAPL) to expand its mobile satellite services network. Theriva Biologics ( TOVX ) shares surged 43% after it said late Thursday that it has been named as one of five finalists for Merck's (MRK) Advance Biotech Grant. Shares of VS MEDIA ( VSME ) advanced 36% following an 11% loss the previous session.

On the losing side, shares of Essa Pharma ( EPIX ) plummeted nearly 70% after it said it is terminating a phase 2 trial evaluating the combination of masofaniten and enzalutamide in patients with metastatic castration-resistant prostate cancer compared with enzalutamide alone. Lexicon Pharmaceuticals ( LXRX ) shares plunged 38% after it said late Thursday that the US Food and Drug Administration denied its new-drug application for Zynquista to treat glycemic control in adults with type 1 diabetes and chronic kidney disease. The FDA said that the benefits of Zynquista do not outweigh the risks in adults. Shares of Advent Technologies ( ADN ) fell more than 15% after a 33% gain on Thursday.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
US Equity Market Mixed as Nasdaq Takes Breather While S&P 500, Dow Touch New Record Highs
US Equity Market Mixed as Nasdaq Takes Breather While S&P 500, Dow Touch New Record Highs
Nov 11, 2024
12:38 PM EST, 11/11/2024 (MT Newswires) -- US equity indexes were mixed in midday trading on Monday as declining technology shares restrained the Nasdaq Composite. The Nasdaq Composite fell 0.1% to 19,264.8. The S&P 500, however, traded 0.2% higher at 6,005.9, after hitting 6,017.31, a new intraday record high. The Dow Jones Industrial Average climbed 0.8% to 44,343.5, also touching...
MicroStrategy Provides Updates on Bitcoin Holdings, Capital Markets Activity; Shares Rise
MicroStrategy Provides Updates on Bitcoin Holdings, Capital Markets Activity; Shares Rise
Nov 11, 2024
12:12 PM EST, 11/11/2024 (MT Newswires) -- MicroStrategy's ( MSTR ) shares were up about 17% in recent Monday trading after the company announced updates regarding its bitcoin purchases and capital market activities. Between Oct. 31 and Nov. 10, the company said it bought about 27,200 bitcoins for nearly $2.03 billion at an average price of about $74,463 per bitcoin,...
Top Midday Stories: Cigna Won't Pursue Combination With Humana; AbbVie Phase 2 Schizophrenia Drug Trials Fail to Meet Primary Endpoints
Top Midday Stories: Cigna Won't Pursue Combination With Humana; AbbVie Phase 2 Schizophrenia Drug Trials Fail to Meet Primary Endpoints
Nov 11, 2024
11:35 AM EST, 11/11/2024 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Monday, as the post-election rally continues. In company news, Cigna Group ( CI ) said Monday it is not pursuing a combination with Humana (HUM), and it expects to communicate that to investors and analysts in meetings over the next several weeks....
US STOCKS-Wall Street hovers near record high as Trump-fueled rally continues
US STOCKS-Wall Street hovers near record high as Trump-fueled rally continues
Nov 11, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window) * Tesla jumps after hitting $1 trillion in market value on Friday * Crypto stocks gain as bitcoin surges * Megacaps, chip stocks lose ground * Russell 2000 up more than 1% * Indexes: Dow up 0.85%, S&P 500 up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved